Mersana Therapeutics, Inc.
MRSN
$0.3659
$0.00982.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 102.29M | 134.62M | 155.17M | 162.74M | 183.15M |
| Total Receivables | -- | -- | 1.00M | 1.57M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.58M | 2.28M | 4.39M | 4.65M | 4.39M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 321.00K | -- | -- | -- | -- |
| Total Current Assets | 106.19M | 136.90M | 160.56M | 168.96M | 187.54M |
|
|
|||||
| Total Current Assets | 106.19M | 136.90M | 160.56M | 168.96M | 187.54M |
| Net Property, Plant & Equipment | 5.63M | 6.78M | 8.00M | 9.19M | 10.36M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 657.00K | 978.00K | 978.00K | 978.00K | 478.00K |
| Total Assets | 112.47M | 144.66M | 169.53M | 179.13M | 198.37M |
|
|
|||||
| Total Accounts Payable | 4.37M | 4.33M | 2.03M | 3.01M | 3.09M |
| Total Accrued Expenses | 12.97M | 18.96M | 18.63M | 17.78M | 15.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.46M | 16.40M | 15.21M | 11.99M | 8.76M |
| Total Finance Division Other Current Liabilities | 24.35M | 22.76M | 32.43M | 29.40M | 25.91M |
| Total Other Current Liabilities | 24.35M | 22.76M | 32.43M | 29.40M | 25.91M |
| Total Current Liabilities | 58.16M | 62.46M | 68.30M | 62.18M | 53.41M |
|
|
|||||
| Total Current Liabilities | 58.16M | 62.46M | 68.30M | 62.18M | 53.41M |
| Long-Term Debt | 7.90M | 10.95M | 14.00M | 17.05M | 20.10M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 262.00K | 1.30M | 2.32M | 3.90M | 4.86M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 77.02M | 79.46M | 83.87M | 87.57M | 92.02M |
| Total Liabilities | 143.34M | 154.17M | 168.48M | 170.70M | 170.39M |
|
|
|||||
| Common Stock & APIC | 888.81M | 886.03M | 882.46M | 878.43M | 873.74M |
| Retained Earnings | -919.68M | -895.55M | -881.44M | -869.94M | -845.67M |
| Treasury Stock & Other | -- | 10.00K | 25.00K | -71.00K | -90.00K |
| Total Common Equity | -30.87M | -9.51M | 1.05M | 8.43M | 27.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -30.87M | -9.51M | 1.05M | 8.43M | 27.99M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -30.87M | -9.51M | 1.05M | 8.43M | 27.99M |
|
|
|||||